WuXi AppTec Co., Ltd. (WX80)

Profile

https://www.wuxiapptec.com

WuXi AppTec Co., Ltd. is an investment holding company specializing in research, development, and manufacturing services for the pharmaceutical and biotechnology industries. It supports the discovery, development, and production of small molecule drugs, oligonucleotides, peptides, complex conjugates, and advanced therapies from target discovery through to commercial manufacturing. Operating across six key segments—WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others—the company delivers contract research, development, and manufacturing organization (CRDMO) services. These encompass biology solutions for integrated projects from candidate selection to clinical stages, impacting sectors like life sciences and medical research globally in regions including China, the United States, and Europe. With a strong financial profile featuring a market capitalization around €22.48 billion, trailing twelve-month revenue of €4.82 billion, and earnings of €1.59 billion, WuXi AppTec Co., Ltd. plays a pivotal role in accelerating drug innovation for clients worldwide, evidenced by high profitability scores and robust growth forecasts in earnings and revenue.